Interestingly, the relationship between FANCE and immune cells in liver hepatocellular carcinoma (LHC), prostate adenocarcinoma (PRAD), breast invasive carcinoma (BRCA), and kidney renal papillary cell carcinoma (KIRP) appears to be completely opposite to that in HNSC. This evidence concerns the gene FANCE and invasive breast carcinoma.